2,2',2'',2'''-(trans-Cyclohexane-1,2-diylbis(azanetriyl))tetraacetic acid hydrate

Catalog No. :
ACMKBJ302
CAS No. :
125572-95-4
Molecular Formula :
C14H24N2O9
Molecular Weight :
364.35

IUPAC Name:2,2',2'',2'''-(((1R,2R)-cyclohexane-1,2-diyl)bis(azanetriyl))tetraacetic acid hydrate

2,2',2'',2'''-(trans-Cyclohexane-1,2-diylbis(azanetriyl))tetraacetic acid hydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$61.00Login to see priceIn stockInquiry
500g98%$222.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2',2'',2'''-(trans-Cyclohexane-1,2-diylbis(azanetriyl))tetraacetic acid hydrate
IUPAC Name2,2',2'',2'''-(((1R,2R)-cyclohexane-1,2-diyl)bis(azanetriyl))tetraacetic acid hydrate
MDL No.MFCD00149243
Molecular FormulaC14H24N2O9
Molecular Weight364.35
SMILESO=C(O)CN(CC(O)=O)[C@H]1[C@H](N(CC(O)=O)CC(O)=O)CCCC1.[H]O[H]
InChI KeyVASZYFIKPKYGNC-DHTOPLTISA-N
Synonym2,2',2'',2'''-((1R,2R)-rel-Cyclohexane-1,2-diylbis(azanetriyl))tetraacetic acid hydrate | DCTA (monohydrate) | Cyclohexane-1,2-diamine-N,N,N',N'-tetraacetic acid monohydrate, trans- | DTXSID20369106 | O10553 | trans-1,2-Diaminocyclohexane-N,N,N',N'-tetraa
CAS No.125572-95-4
PubChem CID2723844

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMKBJ302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMKBJ302 route product structure diagram
    ACMKBJ302125572-95-4 In Stock
Inquiry

2. ACMKBJ302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMKBJ302 route product structure diagram
    ACMKBJ302125572-95-4 In Stock
Inquiry

Comments (0)